A2 Biotherapeutics, Inc. | $80,000,000 | (Jan 10, 2025)
Holly | $2,200,000 | (Jan 10, 2025)
RLTYco | $20,000,000 | (Jan 10, 2025)
Certified by Founder
Lodge
AdirVentures
investor
United States
- New York, NY
- 15/06/2023
- Seed
- $9,000,000
AdirVentures is an investment firm with deep expertise in technology enabled insurance businesses. We focus on insurance carriers, distribution, & business service verticals within the insurance industry. Our team has integrated over 20 acquisitions and been at the forefront of leveraging technology & analytics to drive value in the insurance industry, resulting in industry leading growth rates at leading margins.
Invest Early -
We work with proven operators in supporting their business plan or will invest in earlier stage startups as a lead investor.
Or Later -
We have a long history of revitalizing mature businesses by bringing our technical, operational, and financial resources to bear resulting in top line growth.
- Industry Venture Capital and Private Equity Principals
- Website https://adirvc.com/
- LinkedIn https://www.linkedin.com/company/adirventures/
Air | $35,000,000 | (Jan 10, 2025)
Prudentia Sciences | $7,000,000 | (Jan 10, 2025)
Biosphere | $8,800,000 | (Jan 10, 2025)
RheumaGen | $15,000,000 | (Jan 10, 2025)
Light Horse Therapeutics | $62,000,000 | (Jan 10, 2025)
Abstract(US) | $4,800,000 | (Jan 10, 2025)
PrettyDamnQuick | $25,000,000 | (Jan 10, 2025)
Oxford Cancer Analytics | $11,000,000 | (Jan 10, 2025)